Geffen Residence & Renewal Ltd (TLV:GEFR)
Israel · Delayed Price · Currency is ILS · Price in ILA 83.10
+1.00 (1.22%)
Apr 3, 2026, 1:44 PM IDT
TLV:GEFR Revenue
In the year 2025, Geffen Residence & Renewal had annual revenue of 78.00K ILS, down -40.46%. Geffen Residence & Renewal had revenue of 19.00K in the quarter ending December 31, 2025, a decrease of -24.00%.
Revenue
78.00K
Revenue Growth
-40.46%
P/S Ratio
3,480.64
Revenue / Employee
3.71K
Employees
21
Market Cap
271.49M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 78.00K | -53.00K | -40.46% |
| Dec 31, 2024 | 131.00K | -11.00K | -7.75% |
| Dec 31, 2023 | 142.00K | 82.00K | 136.67% |
| Dec 31, 2022 | 60.00K | -598.00K | -90.88% |
| Dec 31, 2021 | 658.00K | -2.01M | -75.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Evogene | 12.28M |
| Clal Biotechnology Industries | 11.55M |
| BioLineRx | 3.76M |
| XTL Biopharmaceuticals | 3.26M |
| Can-Fite BioPharma | 1.29M |
| BioLight Life Sciences | 21.00K |